Safety and efficacy of an inactivated vaccine against Lactococcus garvieae in rainbow trout (Oncorhynchus mykiss)

Preventive Veterinary Medicine

Volumn 80, Issue 2-3, 2007, Pages 222-229

  Vendrell, Daniel ^a   Balcázar, José Luis ^a   Ruiz Zarzuela, Imanol ^a   de Blas, Ignacio ^a   Gironés, Olivia ^a   Múzquiz, José Luis ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Lactococcus garvieae; Rainbow trout; Side effects; Vaccination

Indexed keywords

BACTERIAL VACCINE; LIVE VACCINE;

ANIMAL; ANIMAL DISEASE; AQUACULTURE; ARTICLE; DOSE RESPONSE; FISH DISEASE; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LACTOCOCCUS; RAINBOW TROUT; SAFETY; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ANIMALS; AQUACULTURE; BACTERIAL VACCINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FISH DISEASES; INJECTIONS, INTRAPERITONEAL; LACTOCOCCUS; ONCORHYNCHUS MYKISS; SAFETY; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME; VACCINES, ATTENUATED;

LACTOCOCCUS; LACTOCOCCUS GARVIEAE; ONCORHYNCHUS MYKISS;

EID: 34247100222     PISSN: 01675877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prevetmed.2007.02.008     Document Type: Article

References (21)

1. Afonso A., Silva J.C.R., and Gomes S. Lactococcus garvieae trout infections in Portugal: a new challenge on fish vaccinology. IBMC News 7 (2003) 4-6
2. Amend, D.F., 1981. Potency testing of fish vaccines. In: Hennessen, W. (Ed.), Fish Biologics: Serodiagnostics and Vaccines. Dev. Biol. Stand. 49, 447-454.
3. Bowden T.J., Lester K., MacLachlan P., and Bricknell I.R. Preliminary study into the short term effects of adjuvants on Atlantic halibut (Hippoglossus hippoglossus L.). Bull. Eur. Assoc. Fish Pathol. 20 (2000) 148-152
4. Ceschia G., Giorgetti G., Giavenni R., and Sarti M. A new problem for Italian trout farms: Streptococcosis in rainbow trout (Oncorhynchus mykiss). Bull. Eur. Assoc. Fish Pathol. 12 (1992) 71-72
5. Doménech A., Prieta J., Fernández-Garayzábal J.F., Collins M.D., Jones D., and Domínguez L. Phenotypic and phylogenetic evidence for a close relationship between Lactococcus garvieae and Enterococcus seriolicida. Microbiologia 9 (1993) 63-68
6. Eldar A., and Ghittino C. Lactococcus garvieae and Streptococcus iniae infections in rainbow trout (Oncorhynchus mykiss): similar, but different diseases. Dis. Aquat. Org. 36 (1999) 227-231
7. European Commission, 1994. General requirements for the Production and Control of Live and Inactivated Vaccines intended for Fish. Directive 81/852/EEC.
8. European Pharmacopoeia. Furunculosis Vaccine (Inactivated, Oil-Adjuvanted, Injectable) for Salmonids. Fourth ed. (2002), European Pharmacopoeia, Strasbourg, France
9. Gilman J., and Myatt M. EpiCalc 2000, Version 1.02 (1998), Brixton Books, Brixton, United Kingdom
10. Gudmundsdóttir S., Lange S., Magnadóttir B., and Gudmundsdóttir B.K. Protection against atypical furunculosis in Atlantic halibut, Hippoglossus hippoglossus (L.); comparison of a commercial furunculosis vaccine and an autogenous vaccine. J. Fish Dis. 26 (2003) 331-338
11. Lewin C.S. Mechanisms of resistance development in aquatic microorganisms. In: Michel C., and Alderman D.J. (Eds). Chemotherapy in Aquaculture: From Theory to Reality (1992), Office International des Epizooties, Paris 288-301
12. Midtlyng P.J., and Lillehaug A. Growth of Atlantic salmon Salmo salar after intraperitoneal administration of vaccines containing adjuvants. Dis. Aquat. Org. 32 (1998) 91-97
13. Midtlyng P.J., Reitan L.J., Lillehaug A., and Ramstad A. Protection, immune responses and side effects in Atlantic salmon (Salmo salar L.) vaccinated against furunculosis by different procedures. Fish Shellfish Immunol. 6 (1996) 599-613
14. Pereira F., Ravelo C., Toranzo A.E., and Romalde J.L. Lactococcus garvieae, an emerging pathogen for the Portuguese trout culture. Bull. Eur. Assoc. Fish Pathol. 24 (2004) 274-279
15. Poppe T.T., and Breck O. Pathology of Atlantic salmon Salmo salar intraperitoneally immunized with oil-adjuvanted vaccine. A case report. Dis. Aquat. Org. 29 (1997) 219-226
16. Ravelo C., Magariños B., Romalde J.L., and Toranzo A.E. Conventional versus miniaturized systems for the phenotypic characterization of Lactococcus garvieae strains. Bull. Eur. Assoc. Fish Pathol. 21 (2001) 136-144
17. Sørum U., and Damsgård B. Effects of anaesthetisation and vaccination on feed intake and growth in Atlantic salmon (Salmo salar L.). Aquaculture 232 (2004) 333-341
18. Thrusfield M., Ortega C., de Blas I., Noordhuizen J.P., and Frankena K. Win Episcope 2.0: improved epidemiological software for veterinary medicine. Vet. Rec. 148 (2001) 567-572
19. Vela A.I., Vázquez J., Gibello A., Blanco M.M., Moreno M.A., Liébana P., Albendea C., Alcalá B., Mendez A., Domínguez L., and Fernández-Garayzábal J.F. Phenotypic and genetic characterization of Lactococcus garvieae isolated in Spain from lactococcosis outbreaks and comparison with isolates of other countries and sources. J. Clin. Microbiol. 38 (2000) 3791-3795
20. Vendrell D., Balcázar J.L., Ruiz-Zarzuela I., de Blas I., Gironés O., and Múzquiz J.L. Lactococcus garvieae in fish: a review. Comp. Immunol. Microbiol. Infect. Dis. 29 (2006) 177-198
21. Zlotkin A., Eldar A., Ghittino C., and Bercovier H. Identification of Lactococcus garvieae by PCR. J. Clin. Microbiol. 36 (1998) 983-985